[
  {
    "ts": "2025-03-05T11:07:57+00:00",
    "headline": "Vertex Pharmaceuticals Leads 3 Value Stocks Offering Estimated Intrinsic Value",
    "summary": "As U.S. markets grapple with the implications of newly imposed tariffs and economic uncertainties, investors are increasingly seeking opportunities in undervalued stocks that may offer intrinsic value amid broader market declines. In this environment, a good stock is often characterized by strong fundamentals and the potential for growth despite external pressures, making it an attractive consideration for those looking to navigate current market challenges.",
    "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-leads-3-value-110757532.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "30223dd4-0e2a-33f5-9be4-9bfd14885f2c",
      "content": {
        "id": "30223dd4-0e2a-33f5-9be4-9bfd14885f2c",
        "contentType": "STORY",
        "title": "Vertex Pharmaceuticals Leads 3 Value Stocks Offering Estimated Intrinsic Value",
        "description": "",
        "summary": "As U.S. markets grapple with the implications of newly imposed tariffs and economic uncertainties, investors are increasingly seeking opportunities in undervalued stocks that may offer intrinsic value amid broader market declines. In this environment, a good stock is often characterized by strong fundamentals and the potential for growth despite external pressures, making it an attractive consideration for those looking to navigate current market challenges.",
        "pubDate": "2025-03-05T11:07:57Z",
        "displayTime": "2025-03-05T11:07:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/da713992716ec87035eff27f58858a3e",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aURC7pMZPipu9ycaWNQk3Q--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/da713992716ec87035eff27f58858a3e.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S_rTPvHqfyCuyyoDoOJr0g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/da713992716ec87035eff27f58858a3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-leads-3-value-110757532.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-leads-3-value-110757532.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "FLUT"
            },
            {
              "symbol": "EQT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]